Impetigo Disease

BASICS

DESCRIPTION
A superficial, intraepidermal, unilocular, vesiculopustular infection. Typically begins as erythematous tender papule that rapidly progresses through a vesicular to a honey-crusted stage. Still debated as to relative importance of staphylococci versus streptococci. Cultures now give over 80% with Staphylococcus aureus alone or combined with group A beta-hemolytic streptococci. Change over past 15 years to predominately Staph. aureus.
  • Bullous impetigo: Staphylococci impetigo that progress rapidly to small to large flaccid bulla. No lymphadenopathy; <30% of cases.
  • Folliculitis: Considered by some to be Staph aureus impetigo of hair follicle
  • Ecthyma: A deeper, ulcerated, impetigo infection often with lymphadenitis
  • System(s) affected: Skin/Exocrine
  • Genetics: N/A
  • Incidence/Prevalence in USA: Unreported
  • Predominant age: 2-5 years
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • May be slow and indolent or rapidly spreading
  • Tender red macule or papule as early lesion
  • Thin roofed vesicle to bullae - usually nontender
  • Pustules
  • Weeping shallow red ulcer
  • Honey-colored crusts
  • Most frequent on face around mouth and nose, or at site of trauma
  • Satellite lesions
  • Often multiple sites
  • Bullae on buttocks, trunk, face
CAUSES
  • Coagulase positive staphylococci - pure culture about 50–90%. More contagious via contact.
  • Beta-hemolytic streptococci - pure culture only about 10% of the time
  • Mixed infections of streptococci and staphylococci common. Data suggest increasing importance of staphylococci over past 15 years.
  • Direct contact or insect vector
  • Can be contamination at trauma site
  • Regional lymphadenopathy
RISK FACTORS
  • Warm, humid environment
  • Tropical or subtropical climate
  • Summer or fall season
  • Minor trauma, insect bites, etc.
  • Poor hygiene, epidemics, during war, etc.
  • Familial spread
  • Poor health with anemia and malnutrition
  • Complication to pediculosis, scabies, chickenpox, eczema
  • Contact dermatitis (Rhus)
  • Burns
  • Atopic dermatitis
  • Contact sports
  • Children in day care

DIAGNOSIS

LABORATORY

None usually required

  • Culture - taken from the base of lesion after removal of crust. Blood agar grows both staphylococci and group A streptococci
  • ASO titer - can be weak positive for streptococci (not usually done)
  • Streptozyme - positive for streptococci (not usually done)

Drugs that may alter lab results: N/A
Disorders that may alter lab results: Streptococci pharyngitis will alter streptococci enzyme tests

PATHOLOGICAL FINDINGS
N/A
SPECIAL TESTS
Cultures as listed under Laboratory
IMAGING
N/A
DIAGNOSTIC PROCEDURES
N/A

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES

Removal of crusts, cleanliness with gentle washing 2-3 times daily. Clean with antibacterial soap, chlorhexidine or betadine.

SURGICAL MEASURES

N/A

ACTIVITY

No restrictions

DIET

No special diet

PATIENT EDUCATION

Good hygiene important to prevent possible spread

FOLLOW UP

PREVENTION/AVOIDANCE

Close attention to family hygiene, particularly hand washing. Avoid crowding. Treat atopic dermatitis.

POSSIBLE COMPLICATIONS
  • Ecthyma
  • Erysipelas
  • Post-streptococcal acute glomerulonephritis
  • Deep cellulitis
  • Bacteremia
  • Osteomyelitis
  • Septic arthritis
  • Pneumonia
  • Lymphadenitis
EXPECTED COURSE AND PROGNOSIS
  • Complete resolution in 7–10 days with treatment
  • Antibiotic treatment will not prevent or halt glomerulonephritis as it will with rheumatic fever
  • If not clear within 7–10 days, culture is necessary to find resistant organism

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Malnutrition and anemia
  • Crowded living conditions
  • Poor hygiene
  • Neglected minor trauma
  • Any chronic dermatitis
AGE-RELATED FACTORS

Pediatric: Impetigo neonatorum may occur by nursery contamination
Geriatric: N/A
Others: N/A

PREGNANCY
  • Only if < 50,000 platelet count, may consider C-section
  • Patient in labor should receive intravenous gamma globulin due to risk to the infant
  • Platelet autoantibodies cross the placenta and may cause neonatal thrombocytopenia. Consider prednisone 10–20 mg/day for 10–14 days prior to delivery.
  • Preeclampsia or gestational thrombocytopenia may cause thrombocytopenia unrelated to ITP
OTHER NOTES

N/A

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.